GFRAL Antikörper (Extracellular, N-Term)

Produktnummer ABIN7886752

Der Kaninchen Polyklonal anti-GFRAL Antikörper wird verwendet zum Nachweis von GFRAL in Proben von Ratte. Er wurde validiert für WB und IHC.

Kurzübersicht für GFRAL Antikörper (Extracellular, N-Term) (ABIN7886752)

Target: GFRAL (GDNF Family Receptor alpha Like (GFRAL))

Reaktivität: Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser GFRAL Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (IHC)

Produktdetails anti-GFRAL Antikörper

Bindungsspezifität: AA 320-334, Extracellular, N-Term

Verwendungszweck: A Rabbit Polyclonal antibody to GFRAL

Sequenz: (C)YPTPNVKDIS SYERK

Homologie: Mouse - 14 out of 15 amino acid residues identical It will not recognize the human protein

Produktmerkmale: Anti-GFRAL (extracellular) Antibody (ABIN7581881) is a highly specific antibody directed against an epitope of the rat protein. The antibody can be used in western blot and immunohistochemistry applications. It has been designed to recognize GFRAL from rat and mouse samples. The antibody will not recognize human GFRAL.

Aufreinigung: Affinity purified on immobilized antigen.

Immunogen: (C)YPTPNVKDISSYERK, corresponding to amino acid residues 320 - 334 of rat GFRAL 

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise:

WB: 1:400

FC: The optimal concentration should be determined by the user

ICC: The optimal concentration should be determined by the user

IHC: 1:200

IP: The optimal concentration should be determined by the user

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: 25 μL, 50 μL or 0.2 mL double distilled water (DDW), depending on the sample size.

Konzentration: 0.8 mg/mL

Buffer: PBS pH 7.4, 1 % BSA with 0.05 % sodium azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C

Details zu GFRAL

Target: GFRAL (GDNF Family Receptor alpha Like (GFRAL))

Andere Bezeichnung: GFRAL

Hintergrund:

Synonyms: GDNF Family Receptor Alpha-Like

Description: GFRAL, also known as GDNF Family Receptor Alpha-Like, is an orphan member of the GFR-α family. GFRAL is a brainstem-restricted receptor for Growth differentiation factor 15 (GDF15), which regulates food intake, energy expenditure and body weight in response to metabolic and toxin-induced stresses. Upon interaction with its ligand GDF15, GFRAL interacts with RET and induces cellular signaling through activation of MAPK- and AKT- signaling pathways.GFRAL regulates body weight and the receptor mediating the metabolic effects of GDF15, enabling potential pharmacotherapies for the treatment of obesity. GFRAL is expressed in neurons of the area postrema and the nucleus of the solitary tract in mice and humans, and genetic deletion of the receptor abrogates the ability of GDF15 to decrease food intake and body weight in mice. Moreover, diet-induced obesity and insulin resistance are exacerbated in GFRAL-deficient mice, suggesting a homeostatic role for this receptor in metabolism1.GDF15, a distant member of the transforming growth factor (TGF)-β family, is a secreted protein that circulates in plasma as a 25- kDa homodimer. In humans, elevated GDF15 correlates with weight loss, and the administration of GDF15 to mice with obesity reduces body weight, at least in part, by decreasing food intake.GDF15 has been implicated in various biological functions, including cancer cachexia, renal and heart failure, atherosclerosis, and metabolism. A connection between GDF15 and body-weight regulation was initially suggested based on an observation that increasing GDF15 levels in serum correlated with weight loss in individuals with advanced prostate cancer. GFRAL-/- mice were refractory to the effects of recombinant human GDF15 on body weight, food intake and glucose parameters. Blocking the interaction between GDF15 and GFRAL with a monoclonal antibody prevented the metabolic effects of GDF15 in rats. GFRAL mRNA is highly expressed in the area postrema of mouse, rat and monkey models, in accordance with previous reports implicating this region of the brain in the metabolic actions of GDF152.The GDNF family includes glial cell line-derived neurotrophic factor (GDNF), artemin (ARTN), Neurturin (NRTN) and persephin (PSPN)3. These factors are heavily involved in the development and function of the nervous system (both central and peripheral). GDNF serves an important role outside the nervous system, where it plays a role in kidney morphogenesis4.In general, GFLs all signal through the receptor tyrosine kinase RET. Their specificity is implemented by different GDNF family receptors a (GFRα), which act as co-receptors. These extracellular proteins are bound to the plasma membrane via a glycosyl phosphatidyl inositol (GPI) anchor. GFRα1-4 are responsible for the binding of GDNF, NRTN, ARTN, and PSPN respectively and the subsequent activation of RET. Soluble forms of the receptor, produced by the cleavage of a yet unknown phospholipase or protease, can be detected. Alternative spliced forms of the protein can also lead to the production of soluble forms of GFRα receptors5.

Gen-ID: 501023

UniProt: D3ZB94